New bioluminogenic substrates for monoamine oxidase assays

Journal of the American Chemical Society

Volumn 128, Issue 10, 2006, Pages 3122-3123

  Zhou, Wenhui ^a   Valley, Michael P ^b   Shultz, John ^b   Hawkins, Erika M ^b   Bernad, Laurent ^a   Good, Troy ^a   Good, Dave ^a   Riss, Terry L ^b   Klaubert, Dieter H ^a   Wood, Keith V ^b  

^a Promega Biosciences Inc   (United States)

^b PROMEGA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;

ALKYLATION; ARTICLE; BINDING AFFINITY; BIOLUMINESCENCE; CHEMICAL STRUCTURE; CYCLIZATION; DEPROTECTION REACTION; ELIMINATION REACTION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REACTION ANALYSIS; SOLUBILITY; STRUCTURE ANALYSIS; SYNTHESIS;

FIREFLY LUCIFERIN; ISOENZYMES; KINETICS; LUMINESCENT AGENTS; MONOAMINE OXIDASE; OXIDATION-REDUCTION; SUBSTRATE SPECIFICITY;

EID: 33644966484     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja058519o     Document Type: Article

References (16)

1. (a) Mandel, S.; Weinreb, O.; Amit, T.; Youdim, M. B. Brain Res. Rev. 2005, 48, 379-387.
2. (b) Youdim, M. B. H.; Bar Am, O.; Yogev-Falach, M.; Weinreb, O.; Maruyama, W.; Naoi, M.; Amit, T. J. Neurosci. Res. 2004, 79, 172-179.
3. Levant, B. Life Sci. 2002, 71, 2691-2700.
4. Kalgutkar, A. S.; Dalvie, D. K.; Castagnoli, N., Jr.; Taylor, T. J. Chem. Res. Toxicol. 2001, 14, 1139-1162.
5. Haugland, R. P. The Handbook: A Guide to Fluorescent Probes and Labeling Technology, 10th ed.: Invitrogen: 2005; p 527.
6. Zhou, J. J. P.; Zhong, B.; Silverman, R. B. Anal. Chem. 1996, 68, 9-12.
7. Chen, G.; Yee, D. J.; Gubernator, N. G.; Sames, D. J. Am. Chem. Soc. 2005, 127, 4544-4545.
8. (a) Amess, R.; Baggett, N.; Darby, P. R.; Goode, A. R.; Vickers, E. E. Carbohydr. Res. 1990, 205, 225-233.
9. (b) Yang, X.; Janatova, J.; Andrade, J. Anal. Biochem. 2005, 336, 102-107.
10. (a) O'Brien, M. A.; Daily, W. J.; Hesselberth, P. E.; Moravec, R. A.; Scurria, M. A.; Klaubert, D. H.; Bulleit, R. F.; Wood, K. V. J. Biomol. Screening 2005, 10, 137-148.
11. (b) Shah, K.; Tung, C. H.; Breakefield, X. O.; Weissleder, R. Mol. Ther. 2005, 11, 926-931.
12. Hawkins, E.; Cali, J. J.; Ho, S. K. S.; O'Brien, M.; Somberg, R.; Bulleit, R. F.; Wood, K. V. WO 2004059294, 2004.
13. Branchini, B. R.; Hayward, M. M.; Bamford, S.; Brennan, P. M.; Lajiness, E. J. Photochem. Photobiol. 1989, 49, 689-695.
14. We thank a reviewer for pointing out that luciferin contamination is always a concern and a possible explanation for the background. A trace of free luciferin or quinolinyl luciferin was detected by highly sensitive fluorescence HPLC and confirmed with authentic samples. However, the fact that the background was not completely eliminated by "burnoff" experiments (pretreatment with luciferase before MAO addition) indicates that other unknown sources, such as autoxidation, might also exist, but the small amount of free luciferin contamination was still the major contributor to the background.
15. (a) Johnston, J. P. Biochem. Pharmacol. 1968, 17, 1285-1297.
16. (b) Tsugeno, Y.; Hirashiki, I.; Ocata. F.; Ito, A. J. Biochem. 1995, 118, 974-980.